Medable Stock

HealthTech

Looking to sell Medable stock or options?

Founded: 2012Funding to Date: $531M

Medable is the developer of a cloud-based platform designed to deliver effective therapies to patients worldwide. Medable's platform encompasses modules such as back-end, analytics, collaboration, compliance, and research survey, all tailored to the strict compliance, interoperability, and privacy concerns of the global healthcare sector. This enables medical practitioners to simplify digital trials, expanding patient access and improving outcomes.

Investors include:

Further Key Investors:

ACVC Partners, Emerson Collective, National Cancer Institute, Launchpad Digital Health, Sapphire Ventures, PROOF, GSR Ventures China, Blackstone, Business Association of Stanford Entrepreneurial Students, Obvious Ventures, Western Technology Investment, Springboard Enterprises, Loren McFarland, MedTech Innovator, Steve Wang, Texas Medical Center, Pharmaceutical Product Development, Streamlined Ventures, Connectivity Ventures Fund, Anula Jayasuriya, North Sky Capital, Ullas Naik.

Looking to sell Medable Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you